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Abstract 
Single crystal x-ray diffraction has been used to investigate the structures of six complexes 
containing O-atom protonated cations derived from the pharmaceutically relevant amides 
benzamide (BEN), paracetamol (PAR) and piperine (PIP). The structures of the salt forms 
[PAR(H)][SO3C6H4Cl], [BEN(H)][O3SC6H4Cl] and [BEN(H)][Br].H2O are reported along with 
those of the hemi-halide salt forms [PAR(H)][I3].PAR ,  [PIP(H)][I3].PIP and 
[PIP(H)][I3]0.5[I]0.5.PIP. The structure of the cocrystal BEN.HOOCCH2Cl is also presented for 
comparison. The geometry of the amide group is found to systematically change upon 
protonation, with the C=O distance increasing and the C-N distance decreasing. The hemi-halide 
species all feature strongly hydrogen bonded amide(H)/amide pairs. The amide group C=O and 
C-N distances for both elements of each such pair are intermediate between those found for 
simple neutral amide and protonated amide forms. It was found that crystallising paracetamol 
from aqueous solutions containing Ba2+ ions gave orthorhombic paracetamol. 
 
Introduction 
It has been shown that although organic amide functionalities are normally thought of as being  
non-basic, it is possible to protonate them using strong acids and even to isolate and characterise 
their salt forms in the solid state. [1-3] Such salt formation reactions are a staple of 
pharmaceutical form screening, where they are used to modify the physicochemical properties of 
basic Active Pharmaceutical Ingredients (APIs).[4] Whilst the acidic materials formed by 
protonating amides are unlikely to make commercially viable APIs, it has been suggested that 
access to such forms may confer substantial benefits during the manufacturing process. For 
instance, salt forms of paracetamol have been shown to have improved compaction properties.[5] 
In 2012 Nanubolu et al. collated the then known crystal structures of a variety of protonated 
amides.[2] Since then several groups have crystallographically investigated series of multiple salt 
forms of particular amide APIs, notably the paracetamol work already mentioned above and 
structures of the model APIs carbamazepine (CBZ) and its congener dihydrocarbamazepine 
(DCBZ).[1, 6-8] The interest in looking at multiple related structures rather than single salt forms 
is of course the increased ability to compare and contrast both structures and the properties that 
arise from these structures. We are particularly interested in the CBZ and DCBZ studies that 
have shown systematic differences between the neutral and protonated forms in terms of both 
molecular structure and of typical hydrogen bonding motifs. [1, 6-8] Here we report an extension 
of these comparative structural studies by examining new salt forms of three pharmaceutically 
relevant amides, the simple building block and primary amide benzamide (BEN), the well known 
analgesic and secondary amide paracetamol (PAR) and the naturally occurring alkaloid and 
tertiary amide piperine (PIP), see Scheme 1. 
 
 
Scheme 1. Molecular structures of amides.  
 
Materials and Methods. 
 
Selected crystallographic and refinement details together with the structure numbers adopted 
throughout are given in Table 1 and Table 2. Displacement ellipsoid figures showing the 
asymmetric unit contents of all structures have been supplied as supplementary information. 
Crystallographic data were measured DWORZWHPSHUDWXUHZLWKPRQRFKURPDWHG0R.ĮȜ 
cRU&X.ĮȜ cUDGiation. Data for structures (1b) and (1c) were measured 
by the UK National Crystallography Service.[9] In all cases structure solution was by direct 
methods (SHELXS or SIR92) and refinement was to convergence on F2 and against all 
independent reflections by the full-matrix least squares method using the SHELX program.[10, 
11] The SQUEEZE routine within PLATON was used to account for residual electron density 
equivalent to approximately 139 electrons within 398 Å3 of unit cell space in compound 
(1b).[12] This is thought to be  due to the presence of small amounts of disordered I2 coformer. 
Assuming this to be true, the electron count corresponds to approximately 0.07 molecules of I2 
per I3 anion.[13] H atoms on O and N atoms were found by difference synthesis but refinement 
of structure (1b) required a riding model to be adopted, with the H atoms in idealized positions. 
CCDC 1563871 through to 1563879 contain the supplementary crystallographic data for this 
paper. These data can be obtained free of charge via 
http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data 
Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033). 
All samples were prepared using general methods described elsewhere. [1, 8] In each case 
approximately 0.2 g of API was dissolved with heating in the minimum amount (2 to 4 ml) of 
methanol. After cooling to room temperature, 2 equivalents of the selected acid were added with 
gentle stirring. Sample vials were sealed with parafilm, which was then pierced to allow slow 
evaporation of solvent. Crystals grew over a period of 2 to 7 days and were measured directly 
from solution. No attempt was made to maximize yield. As well as through the general method 
above, [BEN(H)][Br].H2O (2a) was also isolated after slow addition of acetyl bromide to a 
methanolic solution of BEN. The [PIP(H)][I3]0.5[I]0.5.PIP variant (3b) of the protonated PIP 
structure was formed using ethanol rather than methanol. 
 
 
Results and Discussion 
Salt forms of paracetamol. Of the three chosen amides, PAR is that which has received most 
previous attention from the crystallographic community. As a model API its polymorphs have 
been extensively studied,[14] as have its solvate and cocrystal forms.[15-17] Recently salt forms 
have also been investigated. The structure of the hemichloride [PAR(H)][Cl].PAR has been 
reported, as have the structures of three hydrated species [PAR(H)][X].H2O where X = Cl, Br, I. 
[3, 18, 19] Here we report two further structures including that of the first salt form of PAR with 
an organic anion. The structure of this compound, [PAR(H)][SO3C6H4Cl] (1a), is shown in 
Figure 1 and clearly shows protonation at the O atom of the amide group. Here, and elsewhere in 
this work, the positions of amide H atoms were found by difference synthesis. Although a simple 
hydrated iodide structure of PAR has previously been reported,[19] in our hands the same 
reactants (PAR and aqueous HI) gave a more complicated structure. In detail and ignoring minor 
disorder, the structure of [PAR(H)][I3].(PAR) (1b) contains five crystallographically independent 
PAR(H)-PAR pairs where the formally neutral PAR and formally cationic PAR(H) moieties are 
linked by amide-to-amide O-H...O hydrogen bonds involving the acidic H atoms (Figure 2).  
 
 
Figure 1. Part of the structure of [PAR(H)][SO3C6H4Cl] (1a) showing that each cation forms 
three hydrogen bonds to three separate anions. 
 
 Figure 2. Part of the 1-dimensional hydrogen bonding motif in (1b) that propagates in the 
crystallographic a direction. Shown are two of the five crystallographically unique PAR(H).PAR 
dimers, linked by an unusual phenol to phenol hydrogen bond..  
 
Previously, analysis of CBZ and DCBZ structures showed that protonation of the amide O atom 
led to characteristic lengthening of the C=O bond length and shortening of the C-NH2 and C-
N(ring) bond lengths.[1,7] This effect was so diagnostic of neutral and cationic species that it 
could even be used to assign "intermediate" status to structures where the acidic proton was in 
dynamic equilibrium between CBZ(H) and an O atom of a second crystal component.[6,8] A 
similar analysis of bond length variation for the known PAR(H) species (Scheme 2) is shown in 
Figure 3. As with CBZ and DCBZ, it is clear that protonated and neutral PAR species show 
different geometries with the C=O bond lengthening by approximately 0.05 to 0.06 Å and C-N 
shortening by 0.03 to 0.04 Å upon protonation. These differences are comparable to those found 
for CBZ (0.04 to 0.07 Å lengthening for C=O and 0.02 to 0.04 and 0.03 to 0.05 Å shortening for 
the C-NH2 and C-N(ring) bond lengths respectively). Note that the C-N bond length decrease for 
PAR(H) is not any greater than that found for CBZ(H) species, despite the CBZ(H) species 
having two N centres and thus two alternative resonance forms.[6-8] Figure 3 also shows that the 
hemi-triiodide (1b) and the hemi-chloride structures feature C=O and C-N distances that are 
intermediate between those of neutral and cationic PAR. As the bond lengths within the amide-
to-amide O-+«2K\GURJHQERQGHG PAR(H).PAR pairs do not have clearly defined anionic and 
neutral character this suggests that the H atom may be in dynamic equilibrium between the two 
sites. Similar bond length arguments have been employed to identify dynamic equilibrium in 
CBZ(H) species.[8,14]  
 
Scheme 2. Resonance forms of protonated paracetamol, PAR(H). 
 
 
 
 
 Figure 3. Comparison of C-N and C=O bond lengths (Å) for all known PAR and PAR(H) crystal 
structures. Red diamond = average values based on 66 well characterized neutral PAR species 
available in the CDS database. Green diamonds = cationic PAR(H) species. Blue diamonds = 
hemi-halides, the partially protonated species featuring H shared between hydrogen bonded 
PAR(H) and PAR moieties.  
 
Prior work RQSDUDFHWDPRODQGLWVFRFU\VWDOIRUPVKDVVKRZQWKDWK\GURJHQERQGHG3$5«3$5
chains are robust motifs that commonly occur, either through phenol O-+«2 &LQWHUDFWLRQVRU
where coformer moieties accept hydrogen bonds from the phenolic H, through N-+«2 &
interactions.[15] Cationic PAR(H) has three potential hydrogen bond donors, including the 
presumably strongly donating acidic H. For [PAR(H)][SO3C6H4Cl] (1a) each donor atom forms 
a single hydrogen bond with an O atom of separate neighbouring sulfonate anions, Fig 1. Thus 
this salt form lacks the typical hydrogen bonded paracetamol chains seen elsewhere for neutral 
forms of PAR. The triiodide structure does have a variation of the common hydrogen bonded 
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paracetamol chain motif, with PAR(H).PAR dimers being linked by an unusual motif involving 
the paracetamol phenol group acting as both an acceptor and as a donor. 
It can be seen from Table 3 WKDWWKH2«O distances for the hydrogen bonds involving the amide 
O-H donors of PAR(H) are consistently much shorter than is typical for a O-+«2
interaction.[20] The table and reference 18 shows that this is also true for the other protonated 
amide species. The hemi-species of both PAR and PIP all have hydrogen bonds between 
formally neutral and charged amide O atoms, and these have even shorter 2«2separations than 
the simple salt forms. A final interesting intermolecular interaction occurs in the structure of 
(1a). An oxygen atom of the sulfonate group makes a short contact with the N and C atoms of 
the potonated amide group to form an unusual dipole-GLSROHLQWHUDFWLRQ7KH21DQG2«&
distances are 3.035(3) and 2.962(3) Å respectively, not much longer than the hydrogen bonded 
N«O separations given in Table 3.  
 
 
Other reactions involving paracetamol. During our investigations PAR was also reacted with 
various other strong acids, but analysis of the solids produced showed that these were 
decomposition products formed by hydrolysis of the N-C(amide) bond. Similar problems were 
reported with HCl addition to PAR by Perumalla et al.[5] A typical product was the simple 
salt[H3NC6H4OH][O3SMe],  (1c). Of more interest is the product isolated on reaction of PAR 
with benzenesulfonic acid. This is the hydronium containing species 
[H3NC6H4OH][H3O][O3SC6H5]2.H2O  (1d) shown in Figure 4. A further series of experiments 
involved attempts to produce inorganic cocrystal forms of PAR. To do this, s-block metal salts 
were added to the acidic reaction mixtures. This is analagous to the technique used to prepare 
NaI complexes of CBZ. [21] With PAR no such complexes were obtained but it was observed 
that in the presence of BaCl2 the orthorhombic polymorph of PAR was prepared rather than the 
typical and generally more stable monoclinic form.[14] Further investigation showed that the 
presence of acid was not required to achieve this effect and that simply crystallizing PAR from 
aqueous solutions of BaCl2, BaO or Ba(OH)2 also gave orthorhombic PAR, as judged by unit 
cell determinations and by IR spectroscopy. In contrast, crystallising PAR from aqueous 
solutions containing various salts of Ca, Sr, K, Na and NH4 gave only the monoclinic form of 
PAR. Thomas et al. have previously reported a similar observation that orthorhombic PAR can 
be prepared by recrystallisation in the presence of carboxylic acids,[22] but we are not aware of 
any prior description using inorganic materials. 
 
Figure 4. Asymmetric unit contents of [H3NC6H4OH][H3O][O3SC6H5]2.H2O, (1d). The proton 
positions situated between the water molecules each have a sof of 50%.    
 
Salt and cocrystal forms of benzamide. Benzamide, BEN, is the simplest possible aromatic amide 
and has a special place in crystal science as the first material for which crystalline polymorphs 
were described.[23] Although it is not itself an API, many of its derivatives are. Its fundamental 
nature has resulted in previous interest in the crystal structures of BEN and of its cocrystals. [23, 
24] Only two protonated crystal structures containing the BEN(H) cation have been previously 
described, those of the hemi-triiodide [BEN(H)][I3].BEN and the hydrated perchlorate salt 
[BEN(H)][ClO4].H2O. [25, 26, 27] Reactions were attempted between BEN and: the mineral 
acids HCl and HBr; the sulfonic acid HO3SC6H4Cl, and; the carboxylic acid chloroethanoic acid. 
No reaction was observed with HCl despite several attempts. The other strong acids both gave 
salt forms containing the BEN(H) cation, namely [BEN(H)][Br].H2O (2a) and 
[BEN(H)][O3SC6H4Cl], (2b). The weaker carboxylic acid gave a cocrystalline species, 
BEN.HOOCCH2Cl (2c) with no transfer of H to the amide (Figure 5).  The geometric parameters 
for the BEN(H) cations in the two salt structures are essentially identical and are also similar to 
those of the known perchlorate salt (Table 4). Taking the equivalent parameters for the cocrystal 
(2c) as a comparison shows that for BEN, protonation of the amide at the O atom results in an 
approximate 0.04 Å increase in the C-O length and a small 0.02 Å decrease in the C-N length. 
These changes are smaller than those found for PAR(H), above, and at the low end of the range 
found previously for CBZ(H) and DCBZ(H).[6-8] A further geometric change occurs on 
protonation of BEN as is apparent from Table 4. The O-C-C angle of the BEN(H) fragment has 
narrowed and the N-C-C angle has widened with respect to neutral BEN. An equivalent effect is 
apparent for the other primary amide CBZ but no similar angular changes are observed for the 
secondary amine PAR. 
 
The hydrogen bonded R22(8) heterodimer found in the structure of BEN.HOOCCH2Cl (2c) is 
ubiquitous throughout the known structures of cocrystals of BEN with carboxylic acids.[24] This 
and similar dimeric constructs (e.g. the classic R22(8) carboxylic acid dimer) are known to be 
extremely robust structural motifs. For cocrystals of CBZ with organic acids, a similar 
heterodimer is a typical construct.[28,29] Indeed it was the only typical CBZ hydrogen bonding 
motif to be found for both CBZ and protonated CBZ(H), as illustrated by the structure of 
[CBZ(H)][SO3Ph].[8] However, the structure of  [BEN(H)][O3SC6H4Cl] (2b) shows no such 
retention of the motif  (Figure 5). Instead the three donors of BEN(H) form hydrogen bonds with 
three neighboring sulfonate anions. These hydrogen bonds combine to give a 1-dimensional 
hydrogen bonded construct propagating parallel to the crystallographic a direction. Somewhat 
similarly, the BEN(H) cation in the bromide species (2a) also forms hydrogen bonds with three 
neighbours, in this case with two anions and the water molecule. The large anion and extra water 
molecule of (2a) allow a 2-dimensional hydrogen bonded construct to form, propagating parallel 
to the a and b directions, as compared to the 1-dimensional construct of (2b), Figure 6.   
 
  
  
 
 
 
 
 
 
Figure 5. Each BEN(H) cation in salt forms [BEN(H)][Br].H2O (2a, top) and 
[BEN(H)][O3SC6H4Cl] (2b, middle) donates three hydrogen bonds to three neighbouring 
anions/molecules. However, the hydrogen bonding in the cocrystal BEN.HOOCCH2Cl (2c, 
bottom) is based on the classic amide/carboxylic acid R22(8) heterodimer. 
 
 
 Figure 6. Packing diagram for structure (2a) viewed along the crystallographic a direction. Note 
the formation of hydrophobic and hydrophilic layers. 
  
Salt forms of Piperine. Piperine (PIP) is a tertiary amide and the alkaloid responsible for the hot 
sensation in some varieties of pepper. It is of interest as an API and as an insecticide and as such 
its polymorphism has been studied.[30-32] We are not aware of any prior determinations of 
structures of salt or of cocrystalline forms of PIP. The amide was reacted with the strong acids 
HX (X = Cl, Br or I) but only with HI were novel crystalline products isolated. Growing directly 
from the reaction solutions, two separate hemi-halide species were identified, [PIP(H)][I3].PIP 
(3a) and [PIP(H)][I3]0.5[I]0.5.PIP (3b). The organic parts of the two structures are similar, both are 
discrete hydrogen bonded dimers featuring an acidic H atom sited between the O atoms of the 
two amide groups formally designated as PIP(H) and PIP (Figure 7). This is a similar structure to 
the hemi-halide species described above for the [PAR(H)][X].PAR (X = Cl, I3) species. The I3 
anion of (3a) is disordered. Unsurprisingly, disorder in such an electron rich fragment adversely 
effects the quality of the structural model and so caution is required in any analysis of small bond 
length changes. For (3a) the C=O distances found are 1.279(10) and 1.277(10) Å for the PIP(H) 
and PIP fragments respectively, whilst the C-N distances are 1.330(10) and 1.331(10) Å. The 
equivalent distances for (3b) are 1.269(9), 1.269(9), 1.318(9) and 1.322(9) Å. As for (1b) above, 
the similarities between the PIP(H) and PIP pairs argues against the proton being fixed to one 
position of the discrete hydrogen bonded dimer. Comparing the bond lengths with those of the 
[PAR(H)][X].PAR species (Figure 3) shows a reasonable agreement, whilst comparison with the 
equivalent bonds in neutral PIP shows the expected small increase (0.03 to 0.04 Å) in C=O 
length and decrease (0.02 to 0.03 Å) in C-N distance.[32]  Despite the small magnitude of these 
changes compared to the large su values found in these structures, the sizes of these changes are 
broadly in line with those for the primary and secondary amides described above. With no such 
supporting evidence available for any similar analysis of potential resonance effects along the 
butadiene chain, the small changes observed there between (3a), (3b) and PIP are inconclusive.  
 
Conclusions 
This work presents the single crystal structures of 6 new O-protonated amide species relevant to 
the pharmaceutical community. Three of these are fully protonated salt forms, 
[PAR(H)][SO3C6H4Cl], [BEN(H)][O3SC6H4Cl] and [BEN(H)][Br].H2O, a series that includes 
the first structures of salt forms of paracetamol and of benzamide with organic anions. Three 
structures of hemi-salts are also presented, those of [PAR(H)][I3].PAR ,  [PIP(H)][I3].PIP and 
[PIP(H)][I3]0.5[I]0.5.PIP. Comparison of C=O and C-N bond lengths shows that protonation of all 
the amides utilised here, whether primary, secondary or tertiary, gives similar C=O lengthening 
and C-N shortening effects to those previously described for carbamazepine. The hemi-salts have 
bonds lengths intermediate to those of pure neutral and protonated species. All the amide O-H 
acidic protons form short, strong hydrogen bonds and those formed between protonated and 
neutral amide moieties in the hemi-salts arHIRXQGWRKDYHSDUWLFXODUO\VKRUW2«2GLVWDQFHV
Finally, whilst unsuccessfully investigating a potential route to inorganic cocrystal forms of 
paracetamol via protonated paracetamol, it was observed that crystallizing paracetamol from 
aqueous solutions containing Ba2+ ions gave a repeatable route to the unusual orthorhombic form 
of paracetamol.  
 
  
Figure 7. The acidic H atom of [PIP(H)][I3].PIP (3a) lies between the two amide groups so as to 
form a short hydrogen bond. As this is the only hydrogen bond in this structure, the hydrogen 
bonding is based on this discrete dimer. This structural fragment is common to both (3a) and to 
[PIP(H)][I3]0.5[I]0.5.PIP (3b). 
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Table 1. Selected crystallographic and refinement parameters for structures derived from PAR . 
 
[PAR(H)] 
[SO3C6H4Cl] [PAR(H)][I3].PAR 
[H3NC6H4OH] 
[O3SMe] 
[H3NC6H4OH] 
[H3O][O3SC6H5]2.H2O 
Compound 
number 
1a 1b 1c 1d 
Empirical 
formula 
C14H14ClNO5S C16H19I3N2O4a C7H11NO4S C18H23NO9S2 
Molecular 
Weight 
343.77 684.03 205.23 461.49 
Temperature 
(K) 
123(2) 100(2) 100(2) 123(2) 
Wavelength 
(Å) 
0.71073 0.71073 0.71073 0.71073 
Crystal 
system 
monoclinic monoclinic monoclinic monoclinic 
Space group P21/c P21/n P21/c P21 
a (Å) 17.469(2) 17.4503(12) 8.9880(2) 5.6570(14) 
b (Å) 9.9372(12) 18.5617(13) 13.6977(4) 21.769(5) 
c (Å) 8.7440(15) 33.926(2) 7.3968(2) 8.438(2) 
D(ࣙ) 90 90 90 90 
E(ࣙ) 101.529(13) 100.077(1) 90.290(2) 90.580(3) 
J(ࣙ) 90 90 90 90 
Cell volume 
(Å3) 1487.3(4) 10819.5(13) 910.64(4) 1039.1(4) 
Z 4 20 4 2 
T max(°) 59.28 54.00 53.98 52.94 
Reflections 
collected 
7246 141009 9988 10729 
Reflections 
unique 
3657 23566 1990 3524 
Reflections 
obs. 
2878 19295 1821 3473 
Rint 0.021 0.0467 0.0218 0.0188 
No. 
Parameters 
212 1175 135 311 
GoF 1.043 1.052 1.038 1.045 
R  [,>2V(,)] 0.0419 0.0363 0.0287 0.0243 
Rw (all data) 0.1075 0.0964 0.0745 0.0616 
Largest diff. 
peak and hole 
(e Å-3) 
0.394, -0.477 2.089,-2.536 0.389, -0.354 0.328, -0.239 
Flack 
parameter 
   0.03(5) 
a
 Formula does not include traces of disordered and partially present cocrystallised material. The 
PLATON SQUEEZE program was used for this ± see experimental text. 
  
Table 2. Selected crystallographic and refinement parameters for structures derived from BEN 
and PIP. 
 
[BEN(H)] 
[Br].H2O 
[BEN(H)] 
[SO3C6H4Cl] 
BEN. 
ClCH2COOH 
[PIP(H)] 
[I3].PIP 
[PIP(H)] 
[I3]0.5[I]0.5.PIP 
Compound 
number 
2a 2b 2c 3a 3b 
Empirical 
formula 
C7H10BrNO2 C13H12ClNO4S C9H12ClNO3 C34H39I3N2O6 C34H39I2N2O6 
Molecular 
Weight 
220.07 313.75 217.65 952.37 825.47 
Temperature 
(K) 
123(2) 123(2) 123(2) 123(2) 123(2) 
Wavelength 
(Å) 
0.71073 0.71073 0.71073 1.5418 1.5418 
Crystal 
system 
triclinic triclinic triclinic monoclinic monoclinic 
Space group P-1 P-1 P-1 P21/c P2/c 
a (Å) 5.8036(8) 5.4326(3) 5.0989(5) 10.1661(10) 16.0719(13) 
b (Å) 7.7447(10) 9.0904(4) 7.9040(7) 20.3025(9) 13.0773(12) 
c (Å) 10.2138(13) 13.5037(7) 12.6364(13) 17.3784(8) 16.0097(13) 
D(ࣙ) 73.205(12) 88.304(4) 99.174(8) 90 90 
E(ࣙ) 78.482(11) 85.942(4) 94.552(9) 99.158(7) 90.797(8) 
J(ࣙ) 85.241(11) 86.128(6) 104.102(8) 90 90 
Cell volume 
(Å3) 430.49(10) 663.48(6) 483.87(8) 3541.1(4) 3364.5(5) 
Z 2 2 2 4 4 
T max(°) 58.54 58.56 58.55 138.26 139.04 
Reflections 
collected 
3962 12667 5829 12307 11591 
Reflections 
unique 
2080 3396 2375 6409 6128 
Reflections 
obs. 
1800 3005 1930 3692 4027 
Rint 0.0285 0.0277 0.0309 0.0589 0.0561 
No. 
Parameters 
120 193 139 419 403 
GoF 1.065 1.109 0.973 1.023 1.016 
R  [,>2V(,)] 0.0357 0.0411 0.0401 0.0710 0.0620 
Rw (all data) 0.0870 0.1144 0.1056 0.1978 0.1586 
Largest diff. 
peak and hole 
(e Å-3) 
0.746, -0.828 0.656, -0.465 0.402, -0.259 2.428, -0.917 1.018, -0.820 
 
  
Table 3. Selected hydrogen bonding distances for protonated amides.  
Compound O(amide)-, ?K  
 
K ?KĚŝƐƚĂŶĐĞ   
(Å) 
O(amide)-, ?K  
 
O-, ?KĂŶŐůĞ  
( °) 
Other   
O-, ?K  
K ?K
distances (Å) 
N-, ?K  
 
E ?KĚŝƐƚĂŶĐĞ  
(Å) 
     
[PAR(H)][SO3C6H4Cl]  
(1a) 
2.557(2) 173(4) 2.751(3) 2.826(2) 
[PAR(H)][I3].PAR  
(1b) 
2.418(3) to 
2.435(3) 
162 to 175 2.727(3) to 
2.800(3) 
 
     
[BEN(H)][Br].H2O 
 (2a) 
2.494(3) 176(4)   
[BEN(H)] SO3C6H4Cl]  
(2b) 
2.5033(18) 177(4)  2.874(2), 
2.914(2)  
     
[PIP(H)][I3].PIP  
(3a) 
2.429(8) 173(10)   
[PIP(H)][I3]0.5[I]0.5.PIP  
(3b) 
2.430(7) 171(10)   
 
 
 
 
Table 4. Selected geometric parameters for BEN and BEN(H) species. 
Compound C=O (Å) C-NH2 (Å) O-C-N (°) O-C-C (°) N-C-C (°) 
Salt forms      
[BEN(H)][Br].H2O  (2a) 1.292(3) 1.302(4) 121.4(3) 116.3(3) 122.3(3) 
[BEN(H)][O3SC6H4Cl]  (2b) 1.290(2) 1.303(2) 121.99(16) 115.89(15) 122.07(16) 
[BEN(H)][ClO4].H2O 1.287 1.307 120.6 117.3 121.8 
Cocrystal form      
BEN.HOOCCH2Cl  (2c) 1.249(2) 1.326() 121.72(15) 119.44(14) 118.84(14) 
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